Le Lézard
Classified in: Health
Subjects: NPT, TDS, TRI, FVT

Dr. William Li Presenting at First International Rethinking Cancer Meeting at European Cancer Centre Gustave Roussy in Paris, France


CAMBRIDGE, Mass., Sept. 20, 2017 /PRNewswire-USNewswire/ -- The Angiogenesis Foundation announced today its President and Medical Director, Dr. William Li, will present new groundbreaking scientific and public health data connecting diet with health and disease, at the first international Rethinking Cancer meeting to be held on 21 September, 2017, at the European Cancer Centre Gustave Roussy in Paris, France. Dr. Li's talk will build upon concepts he previously presented at the Vatican, TED2017, and from ideas generated at the Angiogenesis Foundation's 2015 World Food and Health Summit held in Paris.

Rethinking Cancer is the first international congress of its kind bringing together patients, scientists, and clinicians to discuss under-investigated areas of cancer research, particularly the critical role of diet in controlling cancer.

"It's now possible to look deep within the human body to learn how the food we eat and beverages we drink impact our health at the cellular level," said Dr. Li. "Our diet not only feeds our nutritional needs, but also impacts our microbiota, our circulatory system, and our immune system. We can use this kind of scientific knowledge to influence these defense systems and protect our health."

Dr. Li will discuss how rigorous scientific methods are critical for researching the role of diet on health and disease, especially as it pertains to cancer prevention and cancer treatment.

The Angiogenesis Foundation is an independent 501(c)(3) third-party scientific organization that drives innovations in health promotion, disease prevention, and disease treatment through research, education, and advocacy. To learn more about the Angiogenesis Foundation, please visit angio.org.

Established in 1994, the Angiogenesis Foundation's mission is to improve global health through angiogenesis-based treatment and prevention. For more information, visit angio.org.

SOURCE The Angiogenesis Foundation


These press releases may also interest you

at 08:45
The "China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forecast (2024 - 2032)" report has been added to ResearchAndMarkets.com's offering. This market research report provides key insights into the industry's rapid growth...

at 08:40
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, will showcase significant contributions in preclinical and translational oncology research at the American Association for Cancer Research (AACR) 2024...

at 08:38
HFA Architecture + Engineering has expanded its healthcare design team with the addition of Principal and Healthcare Practice Leader Paul Sabal (AIA, ACHA, NCARB, LEED AP).  Sabal is a registered architect and interior designer with more than four...

at 08:35
NanoVibronix, Inc. ("NanoVibronix" or the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has entered into an...

at 08:35
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy® (tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B...

at 08:35
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported financial...



News published on and distributed by: